INTERCYTEX GROUP
Intercytex Group plc, a development stage biotechnology company, engages in the research, development, and commercialization of cell-based therapies for the repair and regeneration of skin and hair. The company, using its integrated cell technology platform, develops living, human cell-based products. Its product programs in development include VAVELTA, a facial rejuvenation and skin damage repair product, which completed Phase II trials; SHEF-1-Stem Cell Line, which would develop a cure for AMD... , the leading cause of blindness in the elderly; ICX-TRC, a hair regeneration product that completed Phase II trials; and ICX-SKN, a skin graft replacement for burns and acute wounds, which completed Phase I trial. The company was founded in 2000 and is headquartered in Cambridge, the United Kingdom.
INTERCYTEX GROUP
Social Links:
Industry:
Beauty Biotechnology Medical
Founded:
1999-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.intercytex.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
43.16 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Pound Sterling GoDaddy SSL Google Adsense Heart Internet
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2008-12-22 | Axordia | Axordia acquired by Intercytex Group | N/A |
Investors List
Excalibur Fund Managers
Excalibur Fund Managers investment in Series D - Intercytex Group
3i Group
3i Group investment in Series D - Intercytex Group
NIF Ventures
NIF Ventures investment in Series D - Intercytex Group
Avlar BioVentures
Avlar BioVentures investment in Series D - Intercytex Group
Scottish Equity Partners
Scottish Equity Partners investment in Series D - Intercytex Group
Scottish Equity Partners
Scottish Equity Partners investment in Venture Round - Intercytex Group
Scottish Equity Partners
Scottish Equity Partners investment in Venture Round - Intercytex Group
Avlar BioVentures
Avlar BioVentures investment in Venture Round - Intercytex Group
Official Site Inspections
http://www.intercytex.com
- Host name: 104.21.5.180
- IP address: 104.21.5.180
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Intercytex Group"
Intercytex Ltd.
Biotech company in the field of cell therapies including skin and hair regeneration products. Currently in clinical phase 3 trials in the USA, Canada and UK, headquartered in Cambridge, …See details»
Intercytex Group - Crunchbase Company Profile & Funding
Intercytex Group plc, a development stage biotechnology company, engages in the research, development, and commercialization of cell-based therapies for the repair and regeneration of …See details»
Intercytex Company Profile 2024: Valuation, Funding & Investors
Intercytex General Information Description. Developer of cell therapy technology designed for the development of innovative regenerative medicine products The company is focused on …See details»
Intercytex - VentureRadar
"Welcome to Intercytex Ltd. We are a UK Regenerative Medicine Company product and services company launced in Nov 2010. We are focussed on developing our lead product ICX-RHY …See details»
Intercytex - Overview, News & Similar companies | ZoomInfo.com
Who is Intercytex. Intercytex Ltd. is a UK Regenerative Medicine product and services company re-launched in Nov 2010. The Company is focused on developing its lead product ICX-RHY …See details»
Intercytex - Cambridge, United Kingdom - bionity.com
Nov 15, 2010 Intercytex is using its fully integrated cell technology platform to develop products that harness the innate ability of human cells to regenerate and repair the body. Intercytex …See details»
Intercytex - Products, Competitors, Financials, Employees, …
Intercytex (ICX.L) is a healthcare company using its proprietary cell therapy technology to develop innovative regenerative medicine products to restore skin and hair. Use the CB Insights …See details»
Intercytex Group - Funding, Financials, Valuation & Investors
Intercytex Group is a biotechnology company developing cell-based therapies for the repair and regeneration of skin and hair. Search Crunchbase. ... How much funding has this organization …See details»
Intercytex Group - Crunchbase
Intercytex Group is a biotechnology company developing cell-based therapies for the repair and regeneration of skin and hair. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log …See details»
Intercytex - Company Profile - Tracxn
Oct 20, 2024 Intercytex ranks 438th among 2294 active competitors. 568 of its competitors are funded while 418 have exited. Overall, Intercytex and its competitors have raised over $21B in …See details»
Intercytex Ltd - LinkedIn
Intercytex Ltd | 443 followers on LinkedIn. Welcome to Intercytex Ltd. We are a UK Regenerative Medicine product and services company, focused on developing our lead product ICX-RHY to …See details»
Intercytex Ltd - amc
4 days ago Intercytex Ltd. Viral Vector/Plasmid. Centre for Cell Manufacturing Ireland (CCMI) Adherent Cells, Bulk Allogeneic Processes, Gene Modified Cells, Patient Specific Processes, …See details»
Intercytex (ICX-RHY/Vavelta Asset) - PitchBook
Intercytex (ICX-RHY/Vavelta Asset) General Information Description. A skin repair and rejuvenation product. The asset has been designed to improve the structure, function and …See details»
Intercytex is leading player in £8.5m government initiative
Dec 5, 2011 Biotechnology business Intercytex is to play a leading role in an £8.5m government initiative to boost the UK's medical sector. The Manchester-based company has been selected …See details»
Intercytex Group - Contacts, Employees, Board Members
Organization. Intercytex Group . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Contacts 1. …See details»
Hair cloning - Wikipedia
One of the first companies to begin experimenting with hair cloning was Intercytex. [2] Intercytex tried to clone new hair follicles from the stem cells harvested from the back of the neck. They …See details»
Intercytex artificial skin heals wounds in tests | Reuters
Intercytex Group Plc, which specializes in cell therapy, said on Tuesday its laboratory-made living skin was fully and consistently integrated into the human body. The group's shares rose 12 ...See details»
What is Intercytex? Company Culture, Mission, Values
Intercytex would like to see a swift end to the toupee business. The company is developing cell-based treatments for skin and hair regeneration. Its ICX-TRC product candidate is injected just …See details»
Hair Cells Regeneration – Intercytex | Research - Farjo
The tissue is sent to Intercytex’s manufacturing facility, where the hair-inductive dermal papilla cells are disassociated from the rest of the follicle. These cells are cultured and expanded in …See details»
King's College London, Intercytex and Debra begin Phase II trial …
Mar 16, 2011 The placebo controlled trial will involve 20 RDEB patients. It will be led by Professor John McGrath, Professor of Molecular Dermatology at King’s College London and …See details»